Susan S. Jick, DSc
Adjunct Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Boston University
DSc, Boston University

Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.

Boston University
Evans Center for Interdisciplinary Biomedical Research

Iodinated contrast agents and risk of hypothyroidism in young children in the United States
04/29/2016 - 10/31/2017 (PI)
Bayer AG

Maternal depression and antidepressant use during pregnancy and risk of childhood autism spectrum disorders in offspring
09/01/2015 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development

A Postmarketing Surveillance Study of Otezla
11/01/2015 - 07/21/2017 (PI)
Celgene Corporation

Study of patients with rare disease
05/27/2016 - 05/26/2017 (Subcontract PI)
EpiSource, LLC Genzyme Corporation

Longitudinal Study of Morbidity and Mortality in Primary Vasculitis
03/01/2015 - 02/28/2017 (PI)
Vasculitis Foundation

Prevalence of hypercalcemia of malignancy (HCM) among cancer patients (C14-018)
02/14/2014 - 12/31/2016 (PI)
Amgen, Inc.

Persistent Side-Effects of 5-Alpha-Reductase Inhibitor Treatment
09/01/2014 - 07/31/2016 (Subcontract PI)
New England Research Institutes NIH NIDDK

Incidence, prevalence and treatment patterns of pediatric pulmonary hypertension in the US
09/21/2015 - 03/31/2016 (PI)
Bayer AG

A study to estimate the prevalence of diabetic nephropathy in a pediatric United States population
12/19/2014 - 06/30/2015 (PI)
Bayer AG

Epidemiology of Giant Cell Tumor of the Bone in the UK - Phase II (C13-135)
12/01/2013 - 04/30/2015 (PI)
Amgen, Inc.

Showing 10 of 14 results. Show All Results


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bornand D, Reinau D, Jick SS, Meier CR. ß-Blockers and the Risk of Depression: A Matched Case-Control Study. Drug Saf. 2022 Jan 19. PMID: 35044637
  2. R Charlier SH, Meier C, Jick SS, Meier CR, Becker C. Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study. Cardiovasc Diabetol. 2022 Jan 04; 21(1):2. PMID: 34983504; PMCID: PMC8729078; DOI: 10.1186/s12933-021-01432-1;
  3. Persson R, Sponholtz T, Vasilakis-Scaramozza C, Hagberg KW, Williams T, Kotecha D, Myles P, Jick SS. Quality and Completeness of Myocardial Infarction Recording in Clinical Practice Research Datalink Aurum. Clin Epidemiol. 2021; 13:745-753.View Related Profiles. PMID: 34471387; PMCID: PMC8403723; DOI: 10.2147/CLEP.S319245;
  4. Ayodele O, Cabral HJ, McManus D, Jick S. The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs). Clin Epidemiol. 2021; 13:661-673.View Related Profiles. PMID: 34377032; PMCID: PMC8349190; DOI: 10.2147/CLEP.S317019;
  5. Jick SS, Oleske DM, Persson R, Zamudio J, Facheris MF. Epidemiology of skin event rates among users of pumps for the subcutaneous administration of drugs for chronic conditions. Curr Med Res Opin. 2021 09; 37(9):1563-1571. PMID: 34241571
  6. Schneider R, Reinau D, Stoffel S, Jick SS, Meier CR, Spoendlin J. Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group. Br J Dermatol. 2021 08; 185(2):343-352. PMID: 33609289
  7. Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids. Rheumatology (Oxford). 2021 04 06; 60(4):1926-1931. PMID: 33159794
  8. Burkard T, Rauch M, Jick SS, Meier CR. Validity of bariatric surgery codes in the UK Clinical Practice Research Datalink (CPRD) GOLD compared with Hospital Episodes Statistics. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):858-867. PMID: 33675245
  9. Mueller AM, Liakoni E, Schneider C, Burkard T, Jick SS, Krähenbühl S, Meier CR, Spoendlin J. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study. J Gen Intern Med. 2021 09; 36(9):2639-2647. PMID: 33751411; PMCID: PMC8390626; DOI: 10.1007/s11606-021-06651-6;
  10. Charlier S, Vavanikunnel J, Becker C, Jick SS, Meier C, Meier CR. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study. J Clin Endocrinol Metab. 2021 01 23; 106(2):554-566. PMID: 33141149
Showing 10 of 309 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 309 publications over 37 distinct years, with a maximum of 27 publications in 2016


Contact for Mentoring:

11 Muzzey St
Lexington MA 02421
Google Map

Jick's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department